The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Mr Jan Cohen
    Born in May 1969
    Individual (2 offsprings)
    Person with significant control
    2017-02-06 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 2
    Stuart, Michael James
    Registered Medical Practitioner born in November 1961
    Individual (4 offsprings)
    Officer
    2014-09-09 ~ now
    OF - director → CIF 0
  • 3
    Mr Simon Cohen
    Born in April 1964
    Individual (2 offsprings)
    Person with significant control
    2017-02-06 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
Ceased 1
  • Mr Michael James Stuart
    Born in November 1961
    Individual (4 offsprings)
    Person with significant control
    2016-04-07 ~ 2017-02-06
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

INNOVATE PHARMACEUTICALS LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Intangible Assets
49,217 GBP2024-09-30
49,217 GBP2023-09-30
Debtors
558 GBP2024-09-30
558 GBP2023-09-30
Cash at bank and in hand
88,432 GBP2024-09-30
88,432 GBP2023-09-30
Current Assets
88,990 GBP2024-09-30
88,990 GBP2023-09-30
Creditors
Current, Amounts falling due within one year
-150,651 GBP2024-09-30
-150,651 GBP2023-09-30
Net Current Assets/Liabilities
-61,661 GBP2024-09-30
-61,661 GBP2023-09-30
Total Assets Less Current Liabilities
-12,444 GBP2024-09-30
-12,444 GBP2023-09-30
Creditors
Non-current, Amounts falling due after one year
-3,108 GBP2024-09-30
-3,108 GBP2023-09-30
Net Assets/Liabilities
-15,552 GBP2024-09-30
-15,552 GBP2023-09-30
Equity
Called up share capital
100 GBP2024-09-30
100 GBP2023-09-30
Retained earnings (accumulated losses)
-15,652 GBP2024-09-30
-15,652 GBP2023-09-30
Equity
-15,552 GBP2024-09-30
-15,552 GBP2023-09-30
Average Number of Employees
02023-10-01 ~ 2024-09-30
12022-10-01 ~ 2023-09-30
Intangible Assets - Gross Cost
Other than goodwill
49,217 GBP2023-09-30
Intangible Assets - Accumulated Amortisation & Impairment
Other than goodwill
0 GBP2023-09-30
Intangible Assets
Other than goodwill
49,217 GBP2024-09-30
49,217 GBP2023-09-30
Other Debtors
Amounts falling due within one year
558 GBP2024-09-30
558 GBP2023-09-30
Bank Borrowings/Overdrafts
Current
1,970 GBP2024-09-30
1,970 GBP2023-09-30
Other Creditors
Current
148,681 GBP2024-09-30
148,681 GBP2023-09-30
Creditors
Current
150,651 GBP2024-09-30
150,651 GBP2023-09-30
Bank Borrowings/Overdrafts
Non-current
3,108 GBP2024-09-30
3,108 GBP2023-09-30

  • INNOVATE PHARMACEUTICALS LIMITED
    Info
    Registered number 09209053
    30 Old Bailey, London EC4M 7AU
    Private Limited Company incorporated on 2014-09-09 (10 years 9 months). The company status is Liquidation.
    The last date of confirmation statement was made at 2024-07-11
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.